News Archive

Don’t miss out on this UNIQUE and FREE networking happy hour.

Meet Rockville business owners and learn more about the resources available to your business.

Some of our resource partners in attendance will be:

• BioHealth Innovation
• Rockville Economic Development, Inc.
• Maryland Women’s Business Center
• Rockville Chamber of Commerce
• Maryland Economic Development Association

Please join us and take advantage of this opportunity to find out what REDI can do for you.

You will want to also be there when this year’s “Rockin’ in Rockville” award is presented!

Planning is officially underway for the 2016 FLC national meeting scheduled for April 26-28 at the Drake Hotel in downtown Chicago. This year, a new technology ‘pitch’ session is under development with The Defense Innovation Initiative – Experimental (DIUx) that will feature a panel of investors who are familiar with early stage technologies, including lower Technology Readiness Level (TRL).

Pitching Ideas

All laboratories are invited to pitch their technologies to the panel of investors! The most promising ideas will be given the opportunity to receive additional support and resources to further assess and develop their concepts for commercialization through licensing, identification of potential collaboration partners, etc. Don’t miss the chance to interact with investors and gain valuable exposure of your lab’s technologies in front of an investment audience.

To submit your technologies for the ‘Pitch’ session, please download and follow the instructions on the attached flyer! For additional questions about tech submissions, contact Program Chair Kathleen McDonald at Kathleen_m@lanl.gov.

Cerecor, a Baltimore pharmaceutical firm planning an preliminary public inventory providing, has launched a brand new medical research of an antidepressant it says will help sufferers who aren’t responding to plain remedies.

The corporate is conducting a randomized double-blind experiment to check a drug generally known as CERC-301 on 104 topics who’re experiencing extreme depressive episodes regardless of receiving different remedies. It’s a Part 2 medical trial, which suggests it’s in search of to show the drug triggers a organic response and has some effectiveness in comparison with a placebo.

According to the U.S. Chamber of Commerce, Maryland is the top state in the nation on its “Innovation and Entrepreneurship” index. Despite this strong environment, the first few years of a startup can be a financial headache.

If you are like many startups and in need of funding, or if you are looking to stretch the funding that you do have, one of the most effective strategies is to take advantage of one of the tax incentives that Maryland has created for technology companies.

In 2002, Scott Dylla, a skinny postdoc with a Minnesota accent, answered a Craigslist ad for a room for rent in Palo Alto. Although he couldn’t afford to move in with Brian Slingerland, then an up-and-coming technology banker at Credit Suisse, the two got to talking.

Two of Slingerland’s aunts had died of cancer. One, only a year after she retired. The other of lung cancer. She’d always smoked Kents.

Are you an entrepreneur and thinking of starting your own company? Are you a small start-up looking for local resources that will help your company succeed? Are you a small company looking to expand and enter the next stage of commercial success? If you said “Yes” to any of these questions, then this WIB event is for you!

Our panel of industry experts from MD TEDCO, BioHealth Innovation, and the Montgomery County Department of Economic Development will provide you with invaluable information about resources their organizations provide to the local business community, including idea/product development, early and late stage funding, and business accelerator programs.

Application Deadline: September 11, 2015

An Information Session Webinar about the NIH-CAP is scheduled for Tuesday, September 1, 2015 at 2:00 pm EDT (11:00 am PDT). For more information and to register for the info session, please click here. This session is open to small businesses for which HHS SBIR and STTR Phase II, Phase IIB, or Phase II portion of Fast-Track award is or was active in the past 5 fiscal years. Projects that ended before August 2010 are not eligible. Awardees from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) can also attend.

In a message to the Johns Hopkins community today, university President Ronald J. Daniels outlined recent initiatives the university and health system are undertaking to “help bend the trajectory of our city.”

As he welcomed students, faculty and staff to the start of a new academic year, Daniels recounted connections that Johns Hopkins has made with Baltimore residents through the Summer Jobs Program, school uniform drive, and ex-offenders hiring program. He also highlighted a new public school partnership, research projects, workforce training, and the upcoming launch of the HopkinsLocal economic inclusion initiative.

Roche said on Friday it had won breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental haemophilia medicine, aiming for a piece of the $11 billion haemophilia drug market.

The Swiss drugmaker said its U.S.-based Genentech unit’s ACE910 secured the fast-track designation as the company prepares separate Phase III trials in 2015 and 2016, the first in patients with haemophilia A with factor VIII inhibitors and the second for patients without inhibitors.

Cross border deals involving digital health startups in Israel are on the rise. In the most recent example, Johns Hopkins Technology Ventures has inked a multiyear agreement with Israeli digital health business Luminox that will set up an accelerator for Israeli digital health startups, among other things.

Luminox refers to itself as a digital health hub. It helps connect early stage companies with U.S. institutions, corporates and strategic partners.